Anuradha Krishnan, BA, research analyst at dQ&A, previews her presentation at the 2025 American Diabetes Association Scientific Sessions, sharing findings from a multi-country survey examining how...
In this expert interview, Tugce Akcan, MD, discusses a novel approach to type 1 diabetes care using OpenAPS and GLP-1 receptor agonists to eliminate the need for prandial insulin boluses and improve patient...
A study presented at the 85th Scientific Sessions of the American Diabetes Association explored how physical and cognitive limitations affect glucometer use in adults aged 65 years and older with type 2...
Continuous glucose monitoring adherence significantly lowers emergency and inpatient visits for diabetes-related complications in people with type 2 diabetes on intensive insulin therapy. The authors...
A new optical device using visible light photoplethysmography accurately measured blood glucose in patients with diabetes, achieving a MARD of 8.8% and 100% clinical agreement in the Consensus Error Grid....
A retrospective cohort study presented at the American Diabetes Association found that combining continuous glucose monitoring (CGM) with GLP-1 agonist therapy led to significantly greater reductions in...
A real-world study of a fasting mimicking diet program showed improved glycemic control, medication reduction, and weight loss in people with type 2 diabetes, with high engagement and satisfaction rates....
